Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greif (GEF-B) Cash & Equivalents (2016 - 2025)

Greif (GEF-B) has disclosed Cash & Equivalents for 17 consecutive years, with $285.2 million as the latest value for Q3 2025.

  • Quarterly Cash & Equivalents rose 46.86% to $285.2 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $285.2 million through Jul 2025, up 46.86% year-over-year, with the annual reading at $197.7 million for FY2024, 9.29% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $285.2 million at Greif, up from $252.7 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $285.2 million in Q3 2025, with the low at $99.8 million in Q3 2021.
  • Average Cash & Equivalents over 5 years is $163.3 million, with a median of $158.5 million recorded in 2023.
  • The sharpest move saw Cash & Equivalents soared 52.49% in 2021, then decreased 1.54% in 2022.
  • Over 5 years, Cash & Equivalents stood at $124.6 million in 2021, then increased by 18.06% to $147.1 million in 2022, then grew by 22.98% to $180.9 million in 2023, then rose by 9.29% to $197.7 million in 2024, then skyrocketed by 44.26% to $285.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $285.2 million, $252.7 million, and $201.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.